“…Over half of the PAF and NPAF treatment arms were conducted in 5 and 3 countries, respectively (PAF: Germany, N = 42, Japan, N = 39, China, N = 34, Turkey, N = 19, United States, N = 19; NPAF: United States, N = 35, China, N = 15, Germany, N = 15). Race or ethnicity demographics were reported in only one study (0.3%) with limited diversity (86% white), while no studies reported race or ethnicity‐stratified outcomes. Seventeen PAF and 16 NPAF treatment arms (PAF: 12 studies; NPAF: 15 studies) were performed in countries with less than four total country treatment arms and were excluded from success rate analyses (PAF: Austria, N = 1, Brazil, N = 1, Canada, N = 2, Hungary, N = 2, Israel, N = 2, Norway, N = 2, Poland, N = 2, Portugal, N = 1, Spain, N = 3, United Kingdom, N = 1; NPAF: Australia, N = 1, Belgium, N = 1, Denmark, N = 1, France, N = 1, Ireland, N = 1, Netherlands, N = 3, Norway, N = 1, Switzerland, N = 1, Turkey, N = 3, Taiwan, N = 1, United Kingdom, N = 2).…”